V. Wright

A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.

R. Baldessarini, J. Harmatz, J. Biederman, 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

Uncovering Modifier Genes of X-Linked Alport Syndrome Using a Novel Multiparent Mouse Model

D. Gatti, R. Korstanje, R. Lennon, 2021, Journal of the American Society of Nephrology : JASN.

Growth deficits in children treated with desipramine: a controlled study.

J. Biederman, T. Spencer, V. Wright, 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings.

R. Baldessarini, J. Harmatz, J. Biederman, 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response.

R. Baldessarini, S. Faraone, J. Biederman, 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

Desipramine and cutaneous reactions in pediatric outpatients.

J. Biederman, V. Wright, B. Bronstein, 1988, The Journal of clinical psychiatry.